Chargement en cours...
A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)
INTRODUCTION: SRC is an oncogene with an essential role in the invasiveness and metastasis of solid tumors including small cell lung cancer (SCLC). Dasatinib is a potent inhibitor of SRC as well as other tyrosine kinases. The primary objective of this study was to determine the efficacy of second-li...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2853764/ https://ncbi.nlm.nih.gov/pubmed/20087228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181cee36e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|